Biocartis

36 articles about Biocartis

• Biocartis Announces Exercise Of The Over-Allotment Option In Full Bringing The Gross Proceeds Of Its Initial Public Offering To Eur115 Million

  5/19/2015

• Biocartis Raises EUR 100 Million In Successful IPO

  4/24/2015

• Biocartis To Develop Rapid Ebola Virus Triage Test

  2/10/2015

• Biocartis To Present At The Annual J.P. Morgan Healthcare Conference

  1/8/2015

• Debiopharm Diagnostics Portfolio Company Biocartis Ships Its First Idylla Instrument

  9/17/2014

• Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™

  9/12/2014

• Biocartis Poised for 2014 Commercial Launch With EUR 30 Million Series E Equity Fundraising

  11/5/2013

• Biocartis Selects ThingWorx for Next-Generation M2M Solution

  9/5/2013

• Biocartis Strengthens Management Team With Chief Commercial Officer

  9/4/2013

• Biocartis Completes $44.5 Million Series D Fund Raising

  12/12/2012

• Immunexpress , Debiopharm, and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis

  6/19/2012

• Biocartis Names Dr. Nayan Gregory Parekh as Chief Executive Officer

  12/1/2011

• Biocartis Nets $100 Million Series C for Diagnostics Work

  11/17/2011

• bioMerieux, Inc. and Biocartis Sign Strategic Partnership in Molecular Diagnostics

  11/4/2010

• Biocartis Raises EUR30 Million in Series 'B' Financing Round

  4/8/2010

• Biocartis Raises EUR10 Million in Series A Financing Round

  10/15/2009